Literature DB >> 8555151

Screening for syphilis in patients with carcinoma of the tongue.

A J Dickenson1, W J Currie, B S Avery.   

Abstract

The oral signs of syphilis have been comprehensively described and can be identified at each stage of the infection. Despite the historical recognition that inadequately treated or untreated syphilitic leukoplakia may undergo malignant transformation, many surgical units no longer routinely screen patients presenting with malignant or premalignant lesions. In this study, five of the 63 patients (8%) who presented with neoplasms of the tongue reacted to syphilis antibodies. These results indicate that syphilis is still prevalent in this group of patients and suggest that serological investigations may be warranted in the initial assessment of all patients with oral cancer.

Entities:  

Mesh:

Year:  1995        PMID: 8555151     DOI: 10.1016/0266-4356(95)90046-2

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  5 in total

Review 1.  [Oral precancerous conditions--an overview].

Authors:  P A Reichart
Journal:  Mund Kiefer Gesichtschir       Date:  2003-06-28

2.  [Late secondary syphilis with ulceration of the tongue during HIV coinfection: case report].

Authors:  P Spornraft-Ragaller; U Boashie; K Friedrich; U Lehmann; M Meurer
Journal:  Hautarzt       Date:  2006-11       Impact factor: 0.751

Review 3.  Chemokine function in periodontal disease and oral cavity cancer.

Authors:  Sinem Esra Sahingur; W Andrew Yeudall
Journal:  Front Immunol       Date:  2015-05-05       Impact factor: 7.561

4.  Squamous cell carcinoma on a syphilitic gumma: A unique presentation.

Authors:  S Rahima; Najeeba Riyaz; E N Abdul Latheef; P M Shyni
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jan-Jun

5.  Comparison of five-year survival rates among patients with oral squamous cell carcinoma with and without association with syphilis: a retrospective case-control study.

Authors:  Moritz Hertel; Leonie Hagedorn; Andrea Maria Schmidt-Westhausen; Henrik Dommisch; Max Heiland; Robert Preissner; Saskia Preissner
Journal:  BMC Cancer       Date:  2022-04-26       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.